Induction Chemotherapy With Lobaplatin and Fluorouracil vs Cisplatin and Fluorouracil Followed by Chemoradiotherapy in Patients With Stage III–IVB Nasopharyngeal Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Induction Chemotherapy With Lobaplatin and Fluorouracil Versus Cisplatin and Fluorouracil Followed by Chemoradiotherapy in Patients With Stage III-IVB Nasopharyngeal Carcinoma: An Open-Label, Non-Inferiority, Randomised, Controlled, Phase 3 Trial
Lancet Oncol 2021 Apr 12;[EPub Ahead of Print], X Lv, X Cao, WX Xia, KY Liu, MY Qiang, L Guo, CN Qian, KJ Cao, HY Mo, XM Li, ZH Li, F Han, YX He, YM Liu, SX Wu, YR Bai, LR Ke, WZ Qiu, H Liang, GY Liu, JJ Miao, WZ Li, SH Lv, X Chen, C Zhao, YQ Xiang, X GuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.